VivoSim Regains Nasdaq Compliance, Projects 500%+ Revenue Growth, and Holds $10.1M Cash
VIVS sits 20% above its 52-week low of $0.314 on light trading volume (0.3× avg).
Summary
VivoSim Labs announced it has regained Nasdaq compliance, holds $10.1M in cash, and expects 500%+ revenue growth in fiscal 2027, though outstanding shares have quadrupled due to warrant exercises.
Key Events · Earnings and Guidance · VIVS
-
Nasdaq Compliance Regained
The Nasdaq Listing Qualifications Staff confirmed VivoSim now meets the $2.5M minimum stockholders' equity requirement, resolving the July 24 delisting notice.
-
Cash Position Bolstered to $10.1M
Preliminary cash on hand as of August 3, 2026 was ~$10.1M, driven by a $5M Lilly milestone payment, $1M escrow release, and $4M financing (net ~$3.6M).
-
500%+ Revenue Growth Guidance for FY2027
Management reiterated guidance for over 500% revenue growth in fiscal 2027, citing progress in marketing NAM-based contract research services to pharma companies.
-
Significant Dilution from Warrant Exercises
9.9M shares were issued upon warrant exercises between July 15-31, 2026, increasing outstanding shares from 3.2M to 13.4M — a 4x increase.
Analysis · VIVS · Life Sciences
VivoSim Labs has resolved its immediate Nasdaq delisting threat by regaining compliance with the $2.5M stockholders' equity requirement, a critical step after the July 24 delisting notice. The company now holds $10.1M in cash, largely from a $5M Lilly milestone and a $4M financing, which extends its runway despite the going concern warning. Management also guided for over 500% revenue growth in fiscal 2027, signaling a potential inflection in its NAM-based contract research services. However, the share count has quadrupled to 13.4M due to warrant exercises, meaning significant dilution has already occurred.
At the time of this filing, VIVS was trading at $0.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $0.31 to $5.30. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.